Literature DB >> 32892122

Laparoscopic right hemicolectomy for metastatic renal cell carcinoma in the ascending colon: A case report.

Masahiro Kataoka1, Yasumitsu Hirano2, Hiroka Kondo2, Shintaro Ishikawa2, Shigeki Yamaguchi2.   

Abstract

INTRODUCTION: Renal cell carcinoma (RCC) arises from the renal parenchyma and is the most common primary malignancy of the kidney. RCC frequently metastasizes to the lung, bone, lymph nodes, and other locations, but rarely to the colon. We report a case of metastatic RCC of the ascending colon that was successfully resected with laparoscopic right hemicolectomy. PRESENTATION OF CASE: The patient is a 65-year-old man who developed hip joint pain and was diagnosed with polymyalgia rheumatica during the first year after laparoscopic right nephrectomy for right RCC. A screening colonoscopy was performed and a tumor was found in the ascending colon. Biopsy strongly suggested metastatic RCC. No other distant metastases were found, and laparoscopic right hemicolectomy was performed. The tumor extended from the mucosa to the subserosa and was diagnosed histopathologically as colonic metastasis of RCC. There were no lymph node metastases in the simultaneously resected mesentery, but venous invasion was observed. DISCUSSION: RCC can metastasize to various organs, but metastasis to the colon is extremely rare. In cases of colon metastasis, abdominal symptoms, hematochezia, or anemia may occur, and their occurrence should be checked during follow-up. Based on past reports, resection of metastatic lesion is considered the most appropriate treatment.
CONCLUSION: Although it is rare for RCC to metastasize to the colon, it is possible. Resection can be recommended for colon metastasis with no other metastases, and colectomy with R0, including the regional mesocolon, may provide a favorable long-term prognosis.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Colonic metastasis; Laparoscopic right hemicolectomy; Renal cell carcinoma

Year:  2020        PMID: 32892122      PMCID: PMC7481497          DOI: 10.1016/j.ijscr.2020.08.050

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Renal cell carcinoma (RCC) is the most common malignancy arising from the kidney and accounts for 2–3% of all malignancies in adults [1]. Nephrectomy can be curative in cases of RCC without distant metastasis, but metastases occur in 20–40% of cases even after curative resection with R0 [2]. The most common sites of metastasis are lung, bone, lymph nodes, liver, adrenal glands, and brain [3]. The gastrointestinal tract, particularly the colon, is an uncommon location for metastasis. In this case, we present a patient who was successfully treated with laparoscopic colectomy for colonic metastasis.

Presentation of case

A 65-year-old man originally presented with symptoms of right back pain and hematuria. Computed tomography (CT) pointed out a 55-mm diameter right renal tumor. The imaging findings were strongly suggestive of right RCC, and the patient underwent laparoscopic right nephrectomy at our hospital. The histopathological diagnosis of the resected tumor was clear cell RCC, pT3, pNX, cM0, v1, ly0, and Stage III according to the Japanese Renal Cell Carcinoma Treatment Code 4th Edition. After surgery, the patient was being monitored by serial CT. Six months after nephrectomy, bilateral hip joint pain appeared. As a result of close inspection, the patient was diagnosed with polymyalgia rheumatica. Steroid treatment was started, and the joint pain improved. Subsequently, screening upper gastrointestinal endoscopy and colonoscopy were performed. Upper gastrointestinal endoscopy showed no abnormalities, but colonoscopy revealed a tumor in the ascending colon (Fig. 1), and the endoscopic biopsy was strongly suggestive of metastatic RCC.
Fig. 1

The tumor in the ascending colon at colonoscopy.

The tumor in the ascending colon at colonoscopy. A CT scan showed a thickened wall in the ascending colon (Fig. 2). There was no lymphadenopathy in the ascending mesocolon and no distant metastases in the lungs or liver.
Fig. 2

Computed tomography shows wall thickening in the ascending colon.

Computed tomography shows wall thickening in the ascending colon. Since it was a single recurrence without other distant metastasis, we performed laparoscopic right hemicolectomy and lymph node dissection by our standard procedure. The operation time was 240 min and the intraoperative blood loss was 75 mL. The tumor in the resected colon was raised and ulcerated in the center (Fig. 3). The histopathological examination confirmed the ascending colon tumor was a metastatic clear cell RCC (Fig. 4A). The tumor extended from the mucosa to the subserosal layer in the ascending colon and the surgical margins were intact.
Fig. 3

Macroscopic inspection of the mass lesion with ulceration in the resected ascending colon.

Fig. 4

A: The tumor was composed of clear cell renal cell carcinoma (hematoxylin and eosin [H&E]; ×100) B: Venous invasion was observed in the resected mesocolon (H&E; ×40).

Macroscopic inspection of the mass lesion with ulceration in the resected ascending colon. A: The tumor was composed of clear cell renal cell carcinoma (hematoxylin and eosin [H&E]; ×100) B: Venous invasion was observed in the resected mesocolon (H&E; ×40). There was no lymph node metastasis in the mesentery that was resected with the colon, but venous invasion was found at two sites (Fig. 4B). There were no complications during the postoperative course, and the patient was discharged on the sixth postoperative day. We are currently continuing to follow up with him.

Discussion

RCC is the most common malignant tumor arising from the renal parenchyma [4]. It is not unusual for RCC to metastasize, and RCC recurrence is reported in 20–40% of patients even after curative resection [2]. Most recurrences occur during the first 5 years after surgery, but at least 5–10% of recurrences are reported after 5 years [5]. RCC is known to metastasize to various organs lymphatically and hematogenously. The most common sites of RCC metastasis are, in descending order, lung (45.2%), bone (29.5%), lymph nodes (20.8%), liver (20.3%), adrenals (8.9%), and brain (8.1%) [3]. Colonic metastases are thought to occur by the hematogenous pathway, but the details are unclear. In our case, there were no suspicious findings of lymph node metastasis or direct invasion, and hematogenous metastasis was suspected. The site of RCC metastasis varied, and no specific trends of colonic metastasis were noted. A systematic review reported in 2014 showed that complete resection of metastatic RCC was beneficial for overall and cancer-specific survival [6]. Resection of the metastatic lesion is the most appropriate local therapy for most organs, and poor prognosis has been reported for unresected cases [7]. As for colonic metastases, the results from other organs may point to a good long-term prognosis if resected with negative surgical margins. Postoperative follow-up is important for patients with RCC because of the high incidence of recurrence. There is no clear guidance on follow-up beyond the 5-year post-operative follow-up recommended by the National Comprehensive Cancer Network. However, Stewart et al. have found that surveillance beyond 5 years reduces the risk of missed recurrence [7], and longer-term follow-up may be necessary for RCC. In the English-language literature between 1995 and 2020, there are only 10 reports of patients undergoing colorectal resection for metastatic RCC after curative nephrectomy [[8], [9], [10], [11], [12], [13], [14], [15]]. A summary of these cases with our case is shown in Table 1. Most of the patients were male (81.8%), and the median age was 65 years (35–84). The leading symptoms included abdominal pain (27.3%) and hematochezia (27.3%), and the sites of metastasis included sigmoid colon (27.2%), hepatic flexure (18.2%), and transverse colon (18.2%). Right hemicolectomy was performed in 5 patients (45.5%), transverse colectomy in 2 patients (18.2%), left hemicolectomy in 2 patients (18.2%), and anterior resection in 2 patients (18.2%).
Table 1

Summary of reported cases of colonic metastases from renal cell carcinoma after nephrectomy.

Publication yearAuthorSexAgeTime to Recurrence (years)SymptomsSiteOperationPrognosis
1996Tokonabe et al. [8]Male837Melena, abdominal massTransverse colonTransverse colectomyNot stated
1998Avital et al. [9]Female725Abdominal painHepatic flexureRight hemicolectomyNot stated
2008Yetkin et al. [10]Male605Fatigue, dyspepsia, abdominal painHepatic flexureRight hemicolectomyNot stated
2010Jadav et al. [11]Female659Abdominal pain, collapseTransverse colonTransverse colectomyNo recurrence (6 years after colectomy)
2013Milovic et al. [12]Male632Irregular stools, bloatingSigmoid colonLeft hemicolectomyNot stated
2013Milovic et al. [12]Male352Nausea, vomitingNot statedRight hemicolectomyRecurrence (bone, brain), died 2.5 years after primary operation
2013Milovic et al. [12]Male394ConstipationIleocecal valveRight hemicolectomyNo recurrence (9 months after colectomy)
2016Vo et al. [13]Male679Nausea, vomiting, abdominal distension, hematocheziaSigmoid colonAnterior resectionRecurrence (6 months after colectomy, liver metastasis)
2019Zhang et al. [14]Male8413HematocheziaSigmoid colonAnterior resectionNo recurrence (9 months after colectomy)
2019Subasi et al. [15]Male635HematocheziaSplenic flexureLeft hemicolectomy, splenectomyNo recurrence (6 months after colectomy)
Our caseMale651Arthritic painAscending colonLaparoscopic right hemicolectomyNo recurrence (3 months after colectomy)
Summary of reported cases of colonic metastases from renal cell carcinoma after nephrectomy. The median time to recurrence after nephrectomy was 5 years (1–13). Four of the cases recurred more than 5 years after nephrectomy, and this result emphasizes the importance of long-term follow-up. Laparoscopic surgery was performed only in our case. In our case, venous invasion was found at two sites in the resected regional mesocolon without lymph node metastasis, and it was suspected to have spread from the colon. There are no references to regional lymph node metastasis in other cases, but there is one other patient with venous invasion in the resected mesocolon. While en-bloc resection of the colon and its regional mesocolon has generally been considered unnecessary in the treatment of metastatic colon tumors, the presence of mesocolic venous invasion in these two cases suggests that metastatic RCC may cause hematogenous metastasis and indicates a necessity for en-bloc resection of the colon and its regional mesocolon. Of the 11 cases, there were 2 recurrences after resection of colon tumors, one of which was reported as death from the original disease. Four patients were free of recurrence for more than 6 months, and one patient had a long-term survival of 6 years. The presence of a case with a favorable long-term prognosis suggests that colectomy with sufficient margins for metastatic RCC may be useful.

Conclusion

The colon is an uncommon but potentially site of metastasis for RCC. If abdominal symptoms, hematochezia, or anemia are observed during postoperative follow-up for RCC, colon metastasis should be considered. Colon metastasis with no other distant metastases should be considered for en-bloc resection of colon and its regional mesocolon, and complete resection with negative margins may result in long-term survival. This study has been presented in line with SCARE criteria [16].

Declaration of Competing Interest

The authors report no declarations of interest.

Funding

All authors have no funding of research.

Ethical approval

This study is exempt from ethical approval in our institution.

Consent

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.

Author contribution

Masahiro Kataoka: Writing original graft. Yasumitsu Hirano: Supervision, review and editing. Hiroka Kondo: Reviewing. Shintaro Ishikawa: Reviewing. Shigeki Yamaguchi: Supervision, review and editing.

Registration of research studies

N/A.

Guarantor

Masahiro Kataoka.

Provenance and peer review

Not commissioned, externally peer-reviewed.
  16 in total

1.  Solitary colonic metastasis of renal cell carcinoma.

Authors:  G Yetkin; M Uludağ; A Ozağari
Journal:  Acta Chir Belg       Date:  2008 Mar-Apr       Impact factor: 1.090

2.  Solitary colonic metastasis of renal cell carcinoma seven years after nephrectomy: a case report.

Authors:  S Tokonabe; M Sugimoto; Y Komine; H Horii; S Matsukuma
Journal:  Int J Urol       Date:  1996-11       Impact factor: 3.369

3.  Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.

Authors:  Suzanne B Stewart; R Houston Thompson; Sarah P Psutka; John C Cheville; Christine M Lohse; Stephen A Boorjian; Bradley C Leibovich
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

4.  Solitary colonic metastasis from renal cell carcinoma presenting as a surgical emergency nine years post-nephrectomy.

Authors:  Alka M Jadav; Sri G Thrumurthy; Bernard A DeSousa
Journal:  World J Surg Oncol       Date:  2010-06-29       Impact factor: 2.754

5.  Recurrence of renal cell carcinoma more than 5 years after nephrectomy.

Authors:  Kohsuke Uchida; Noriomi Miyao; Naoya Masumori; Atsushi Takahashi; Toshiro Oda; Masahiro Yanase; Hiroshi Kitamura; Naoki Itoh; Masaaki Sato; Taiji Tsukamoto
Journal:  Int J Urol       Date:  2002-01       Impact factor: 3.369

6.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

Authors:  M Bianchi; M Sun; C Jeldres; S F Shariat; Q-D Trinh; A Briganti; Z Tian; J Schmitges; M Graefen; P Perrotte; M Menon; F Montorsi; P I Karakiewicz
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

Review 7.  Nephrectomy in metastatic renal cell carcinoma.

Authors:  Steven C Campbell; Robert C Flanigan; Joseph I Clark
Journal:  Curr Treat Options Oncol       Date:  2003-10

Review 8.  Renal cell carcinoma.

Authors:  Brian I Rini; Steven C Campbell; Bernard Escudier
Journal:  Lancet       Date:  2009-03-05       Impact factor: 79.321

9.  Asynchronous abdominal wall and sigmoid metastases in clear cell renal cell carcinoma: A case report and literature review.

Authors:  Fangyuan Zhang; Gang Zhao; Pengjie Wu; Qi An; Yang Yang; Xin Chen; Jianye Wang; Dong Wei
Journal:  Asian J Urol       Date:  2018-01-06

10.  Solitary colon metastasis from renal cell carcinoma nine years after nephrectomy: A case report.

Authors:  Elaine Vo; Carlos H Palacio; Ronald Omino; Richard E Link; Yvonne Sada; Artinyan Avo
Journal:  Int J Surg Case Rep       Date:  2016-08-03
View more
  1 in total

1.  Metastatic renal cell carcinoma to pancreas and gastrointestinal tract: a clinicopathological study of 3 cases and review of literature.

Authors:  Jamshid Abdul-Ghafar; Nasir Ud Din; Ramin Saadaat; Zubair Ahmad
Journal:  BMC Urol       Date:  2021-05-25       Impact factor: 2.264

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.